Tech Company M&A Transactions

Agensys Acquisition

Agensys, based in Santa Monica, was acquired by Astellas Pharma. The transaction price was $387 million.

Transaction Overview

Company Name
Acquired By
Announced On
Transaction Type
M&A Terms
All cash transaction of $387 million up front plus the addition of a maximum of $150 million in performance and milestone earnout.

Company Information

Company Status
Acquired or Merged
Mailing Address
1545 17th St.
Santa Monica, CA 90404
Email Address
Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets.
Agensys LinkedIn Company Profile
Social Media
Agensys Company Twitter Account
Company News
Agensys News
Agensys on Facebook
Agensys on YouTube

Management Team

Email & Social
Chief Executive Officer
Donald Rice
  Donald Rice LinkedIn Profile  Donald Rice Twitter Account  Donald Rice News  Donald Rice on Facebook
Chief Financial Officer
Paul Kanan
  Paul Kanan LinkedIn Profile  Paul Kanan Twitter Account  Paul Kanan News  Paul Kanan on Facebook
Chief Scientific Officer
Aya Jakobovits
  Aya Jakobovits LinkedIn Profile  Aya Jakobovits Twitter Account  Aya Jakobovits News  Aya Jakobovits on Facebook
VP - Bus. Development
Christopher Morl
  Christopher Morl LinkedIn Profile  Christopher Morl Twitter Account  Christopher Morl News  Christopher Morl on Facebook



Browse more venture capital transactions:

Prev: 11/27/2007: Platform Solutions venture capital transaction
Next: 11/27/2007: Qwaq venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC transactions on this site come from publicly available VC deal announcements. The information is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary